Clinical Trial Update: Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model

View source ↗

Summary

A completed clinical trial from Abramson Cancer Center at Penn Medicine evaluated an alternative genetics-based cancer care delivery model, with relevance to pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genetic Predisposition to Disease
• Hereditary Cancer
• Pancreatic Cancer
• Prostate Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Pancreas Cancer, Prostate Cancer | Status: COMPLETED